Subgroups according to BASDAI/ASDAS category (baseline)

Standardized ASDAS vs standardized SASDAS for (A) baseline pooled data

Evaluation of performance of BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) in a Brazilian cohort of 1492 patients with spondyloarthritis: data from the Brazilian Registry of Spondyloarthritides (RBE) – topic of research

Frontiers Targeted Therapies in Axial Psoriatic Arthritis

Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis

Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab

Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis

Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis - The Lancet Rheumatology

Delayed treatment with a tumor necrosis factor alpha blocker associated with worse outcomes in patients with spondyloarthritis: data from the Czech National Registry ATTRA - Tomas Milota, Jana Hurnakova, Karel Pavelka, Zlatuse

Full article: POSTER PRESENTATIONS

Frontiers The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis

JCM, Free Full-Text